The state of the art in non-small cell lung cancer immunotherapy
- PMID: 24952755
- DOI: 10.1053/j.semtcvs.2014.02.005
The state of the art in non-small cell lung cancer immunotherapy
Abstract
Once considered an ineffective modality in lung cancer, immunotherapy has emerged as one of the most promising therapeutic strategies for this lethal disease. The past few years have seen a plethora of clinical trials evaluating various immunotherapeutic approaches in lung cancer. This article discusses the current status of immunotherapy in non-small cell lung cancer with a review of completed studies and ongoing trials.
Keywords: CTLA-4; PD-1/PD-L1; immunotherapy; lung cancer vaccines; non–small cell lung cancer.
Copyright © 2014 Elsevier Inc. All rights reserved.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous